01Billing team should implement prior authorization and documentation compliance for dental claims under Policy #D020, ensuring all claims include sufficient documentation in the member's dental record to verify service performed and level of care delivered, or claims will be denied.
02Update authorization protocols for Policy #141 (Kidney Transplant) and Policy #185 (Negative Pressure Wound Therapy) to require InterQual guidelines compliance; for kidney transplant, also accept recommendations from Optum Center of Excellence.
03Update authorization for Policy #622 (Spinal Fusion) to require InterQual guidelines compliance.
04Implement non-coverage edits in billing system for Policy #704 (Nidra—restless legs syndrome), Policy #698 (MARPE device), Policy #654 (Curonix PNS for knee osteoarthritis), Policy #514 (WGS/WES for solid tumors), Policy #570 (WGS/WES solid tumor tissue), and Policy #673 (ctDNA surveillance in Stage II colorectal cancer)—claims for these will be denied.
05Update coverage criteria for Policy #336 (Stereotactic Radiation Therapy) to include non-optimal surgical candidates with stages T1a and T1b.
06Shift patient responsibility for non-covered panniculectomy under Policy #463 exclusively to members (cosmetic classification).
07Coding team should review new policies CR-110 (Time-Based Procedure Codes) and CR-106 (MUE) effective 8/21 and 8/27/2026 respectively; verify whether practice has implemented these retrospectively.
08Update claims processing to reference Policy #123 (Gene Therapy, Testing, Counseling) instead of archived Policy #SH/GENETICS-A23.
09For all appeals, ensure submitted documentation is signed and the same signed documentation accompanies any appeal request.
10Affected plans: Commercial (unless summary text is bold, indicating broader applicability).